Danielle Porter
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 detection and testing
- Viral Infections and Outbreaks Research
- Virology top 2%
Papers in
-
- SARS-CoV-2 and COVID-19 Research 22
- HIV/AIDS drug development and treatment 20
- COVID-19 Clinical Research Studies 12
- Viral Infections and Outbreaks Research 10
- Viral gastroenteritis research and epidemiology 7
- Viral Infections and Vectors 6
- Epidemiology 11
- Respiratory viral infections research 8
- Co-authors
- Joy Y. Feng (9 shared papers)Matthias Götte (9 shared papers)Egor P. Tchesnokov (8 shared papers)Calvin J. Gordon (6 shared papers)Jason K. Perry (14 shared papers)Emma Woolner (3 shared papers)Tomáš Cihlář (15 shared papers)Darius Babusis (5 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Antiviral Research (5 papers)Journal of Biological Chemistry (5 papers)The Journal of Infectious Diseases (4 papers)Journal of the International AIDS Society (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Danielle Porter
58 papers receiving 4.5k citations
Danielle Porter's Hit Papers
Peers
Comparison fields: 5 of 125
- Infectious Diseases 3.7k
- Virology 288
- Neurology 525
- Computational Theory and Mathematics 485
- Modeling and Simulation 94
Countries citing papers authored by Danielle Porter
This map shows the geographic impact of Danielle Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Porter more than expected).
Fields of papers citing papers by Danielle Porter
This network shows the impact of papers produced by Danielle Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Porter. The network helps show where Danielle Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside Danielle Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Hit paper breakdown → | 2020 | 1274 |
| 2 | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency Hit paper breakdown → | 2020 | 730 |
| 3 | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus Hit paper breakdown → | 2020 | 644 |
| 4 | Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir Hit paper breakdown → | 2019 | 472 |
| 5 | Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms Hit paper breakdown → | 2022 | 149 |
| 6 | 2020 | 121 | |
| 7 | 2021 | 100 | |
| 8 | 2013 | 95 | |
| 9 | 2014 | 95 | |
| 10 | 2013 | 92 | |
| 11 | 2021 | 59 | |
| 12 | 2020 | 53 | |
| 13 | 2022 | 49 | |
| 14 | 2020 | 48 | |
| 15 | 2020 | 43 | |
| 16 | 2018 | 42 | |
| 17 | 2019 | 36 | |
| 18 | 2017 | 36 | |
| 19 | 2022 | 33 | |
| 20 | 2016 | 33 |
About Danielle Porter
Danielle Porter is a scholar working on Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine, Virology and Molecular Biology, having authored 60 papers that have together received 4.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (22 papers), HIV/AIDS drug development and treatment (20 papers), COVID-19 Clinical Research Studies (12 papers), Viral Infections and Outbreaks Research (10 papers), Respiratory viral infections research (8 papers), Viral gastroenteritis research and epidemiology (7 papers), Viral Infections and Vectors (6 papers) and Viral Infections and Immunology Research (5 papers). The work is most often cited by research in Infectious Diseases (3.7k citations), Virology (288 citations), Neurology (525 citations), Computational Theory and Mathematics (485 citations) and Modeling and Simulation (94 citations). Danielle Porter has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Joy Y. Feng, Matthias Götte, Egor P. Tchesnokov, Calvin J. Gordon, Jason K. Perry, Emma Woolner, Tomáš Cihlář, Darius Babusis, Timothy P. Sheahan and Ralph S. Baric. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral Research, Journal of Biological Chemistry, The Journal of Infectious Diseases and Journal of the International AIDS Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.